SCHEMBL20125038

SCHEMBL20125038

Cc1cc(Cl)c2[nH]cnc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.41
CHEK1 O14757 1/20 0.41
PIM1 P11309 1/20 0.41
RPS6KA3 P51812 1/20 0.41
MAPT P10636 4/20 0.39
AR P10275 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ALDH1A1 P00352 3/20 0.33
CSNK2A1 P68400 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
XDH P47989 1/20 0.33
KMT2A Q03164 2/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18554387 0.80 MAPT (0.39) PARP1CHEK1PIM1MAPTNPC1
SCHEMBL8404371 0.79 PARP1 (0.43) PARP1CHEK1PIM1RPS6KA3MAPT
SCHEMBL20471835 0.79 ALDH1A1 (0.43) PARP1MAPTARNPC1RAB9A
SCHEMBL4157384 0.76 PARP1 (0.41) PARP1CHEK1PIM1RPS6KA3MAPT
SCHEMBL18966973 0.76 MAPT (0.43) PARP1MAPTALDH1A1CSNK2A1KDM4E
SCHEMBL7035006 0.76 PRKCI (0.41) PARP1MAPTALDH1A1XDHKDM4E
SCHEMBL539264 0.76 PARP1 (0.41) PARP1CHEK1PIM1RPS6KA3MAPT
SCHEMBL18687816 0.76 PARP1 (0.44) PARP1CHEK1PIM1RPS6KA3MAPT
SCHEMBL23847839 0.76 MAPT (0.40) PARP1MAPTTP53HSD17B10ALDH1A1
SCHEMBL20910116 0.76 MAPT (0.36) PARP1MAPTNPC1TP53HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020150675-A1 COMPOUNDS AND USES THEREOF NUVATION BIO INC. (US) 2020-07-23 WO disclosed
WO-2020150674-A1 HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS NUVATION BIO INC. (US) 2020-07-23 WO disclosed
WO-2019074979-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF GIRAFPHARMA, LLC (US) 2019-04-18 WO disclosed
EP-3318557-A2 QUINOLONE COMPOUND Otsuka Pharmaceutical Co., Ltd. (JP) 2018-05-09 EP disclosed